Ziad P.

About Ziad P.

Executable rather than theoretical, drove a sovereign‑fund‑mandated, 110M+ net‑revenue commercial carve‑out of SEHA’s non‑profit laboratories into Union71. As CEO, led its merger into PureHealth, establishing ADQ’s ownership stake in what became the UAE’s largest integrated healthcare system. Leveraged this experience building a lab business infrastructure from scratch to drive CCL reference‑lab 5‑year CAGR of 13%. Reference‑lab P&L growth, laboratory build‑outs and commercialization, and go‑to‑market execution across U.S. and international markets. Operational fluency — clinical and technical lab operations, manpower and supply chain, laboratory planning and activation, financial architecture, and multi‑stakeholder management. • Drove sustained Cleveland Clinic reference‑laboratory gross revenue growth from 65M in 2022 to 117M in 2025. • Advised system C-suites and Board of Directors supporting system strategy, major business‑case development, and external consulting partnerships for domestic and international health systems. • Managed P&L up to 110M USD and 15M+ tests annually with direct reports including COO, CAO, CMO, and Director of Strategy. • Architected and activated laboratories across pandemic response, greenfield international builds, new facility commissioning, and cross-border consulting engagements — from clinical workflow design and cost modeling through operational launch. Work sits at the intersection of clinical care, laboratory operations, and revenue performance — from institutional strategy and board-level engagement down to front-line P&L and go-to-market execution, across U.S. and international markets.

Experience

1. Medical Director, Cleveland Clinic Reference Laboratory

   Cleveland Clinic

   Aug 2021 — Present · Cleveland, OH, US

   Serve as the physician leader overseeing Cleveland Clinic reference laboratory, leveraging the Cleveland Clinic’s integrated healthcare ecosystem to deliver high-quality laboratory diagnostics, anatomic pathology expertise, and clinical consultation to clients locally and globally.• High-growth laboratory outreach service for independent community physicians in a competitive commercial regional landscape (~15% 5-year CAGR).• High-growth anatomic pathology consult service extending subspecialty expertise to external pathologists and clinicians worldwide (~11% 5-year CAGR).• Bridge external clients with clinical and technical operations, ensuring diagnostic quality, clinical appropriateness, and seamless integration into varied office and client workflows.• Own strategy development and execution, operational restructuring, and performance optimization, with accountability for P&L, pricing, and marketing in support of sustainable, mission-aligned growth.• Evaluate, negotiate, and develop partnerships with health systems, physician groups, and research organizations within a complex shared governance model.• Delivered gross revenue growth from $65M to $117M from 2022–2025 while maintaining quality, service, and a non-profit, patient-centered focus.

Education

• Tufts University

  B.S., Biology

  1995 — 1999

• The University of Texas Medical Branch

  M,D., Medicine

  2001 — 2005